Both in Lab Analytical Instruments
Nautilus Biotechnolgy vs Pacific Biosciences of California
Over the past year NAUT returned +44.0% and PACB returned +27.5%; their daily moves had a correlation of 0.23.
NAUT +44.0% PACB +27.5%Growth of $1, one year, split-adjusted
| Metric | NAUT | PACB |
|---|---|---|
| Price | $2.29 | $2.55 |
| Market cap | $291.7M | $792.6M |
| Today | −2.55% | +4.51% |
| 1 month | +29.4% | −5.6% |
| 6 months | −22.1% | +49.1% |
| Year to date | +17.4% | +36.4% |
| 1 year | +23.8% | +13.8% |
| Revenue growth (YoY) | — | −1.9% |
| Gross margin | 89.7% | 32.4% |
| Net margin | −6682.1% | −114.7% |
| P/E (TTM) | — | — |
| Price / sales | 687.9× | 5.0× |
| Net cash | $86.6M | -$407.5M |
| Dividend yield | — | — |
| Volatility (60d) | 156.2% | 116.6% |
| Short % of float | 10.4% | 18.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).